169 related articles for article (PubMed ID: 10953325)
1. Inhibition of growth and regulation of IGFs and VEGF in human prostate cancer cell lines by shikonin analogue 93/637 (SA).
Gaddipati JP; Mani H; Shefali ; Raj K; Mathad VT; Bhaduri AP; Maheshwari RK
Anticancer Res; 2000; 20(4):2547-52. PubMed ID: 10953325
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
[TBL] [Abstract][Full Text] [Related]
3. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells.
Stewart LV; Weigel NL
Prostate; 2005 Jun; 64(1):9-19. PubMed ID: 15651061
[TBL] [Abstract][Full Text] [Related]
4. Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I.
Akagi Y; Liu W; Zebrowski B; Xie K; Ellis LM
Cancer Res; 1998 Sep; 58(17):4008-14. PubMed ID: 9731515
[TBL] [Abstract][Full Text] [Related]
5. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
Arnold JT; Le H; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
Grzmil M; Hemmerlein B; Thelen P; Schweyer S; Burfeind P
J Pathol; 2004 Jan; 202(1):50-9. PubMed ID: 14694521
[TBL] [Abstract][Full Text] [Related]
8. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
[TBL] [Abstract][Full Text] [Related]
9. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).
Nickerson T; Chang F; Lorimer D; Smeekens SP; Sawyers CL; Pollak M
Cancer Res; 2001 Aug; 61(16):6276-80. PubMed ID: 11507082
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo expression of angiogenic growth factors and their receptors in human penile cavernosal cells.
Rajasekaran M; Kasyan A; Allilain W; Monga M
J Androl; 2003; 24(1):85-90. PubMed ID: 12514088
[TBL] [Abstract][Full Text] [Related]
11. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
[TBL] [Abstract][Full Text] [Related]
12. Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.
Keledjian K; Kyprianou N
J Urol; 2003 Mar; 169(3):1150-6. PubMed ID: 12576871
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of messenger ribonucleic acids encoding IGF-I, IGF-II, type I and II IGF receptors and IGF-binding proteins (IGFBP-1 to -6) during follicular development in the ovary of seasonally anoestrous ewes.
Hastie PM; Onagbesan OM; Haresign W
Anim Reprod Sci; 2004 Aug; 84(1-2):93-105. PubMed ID: 15302390
[TBL] [Abstract][Full Text] [Related]
14. IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC-3): differential effect on PC-3 and normal prostate cell growth.
Kaicer E; Blat C; Imbenotte J; Troalen F; Cussenot O; Calvo F; Harel L
Growth Regul; 1993 Sep; 3(3):180-9. PubMed ID: 7693099
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
Heinrich E; Schally AV; Buchholz S; Rick FG; Halmos G; Mile M; Groot K; Hohla F; Zarandi M; Varga JL
Prostate; 2008 Dec; 68(16):1763-72. PubMed ID: 18729085
[TBL] [Abstract][Full Text] [Related]
16. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
Jackson MW; Roberts JS; Heckford SE; Ricciardelli C; Stahl J; Choong C; Horsfall DJ; Tilley WD
Cancer Res; 2002 Feb; 62(3):854-9. PubMed ID: 11830543
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.
Ravindranath N; Wion D; Brachet P; Djakiew D
J Androl; 2001; 22(3):432-43. PubMed ID: 11330643
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade.
Liao Y; Abel U; Grobholz R; Hermani A; Trojan L; Angel P; Mayer D
Hum Pathol; 2005 Nov; 36(11):1186-96. PubMed ID: 16260272
[TBL] [Abstract][Full Text] [Related]
20. Distinct expression pattern of insulin-like growth factor family in rodent taste buds.
Suzuki Y; Takeda M; Sakakura Y; Suzuki N
J Comp Neurol; 2005 Jan; 482(1):74-84. PubMed ID: 15612015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
